Oscar Health shares dip as Centene withdraws 2025 guidance citing elevated market morbidity; Oscar reaffirms its full-year outlook after Q1 beat.
Oscar Health shares dip as Centene withdraws 2025 guidance citing elevated market morbidity; Oscar reaffirms its full-year outlook after Q1 beat.